MX2022010442A - Sal de potasio del acido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)pipe razin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4- il]acetico. - Google Patents

Sal de potasio del acido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)pipe razin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4- il]acetico.

Info

Publication number
MX2022010442A
MX2022010442A MX2022010442A MX2022010442A MX2022010442A MX 2022010442 A MX2022010442 A MX 2022010442A MX 2022010442 A MX2022010442 A MX 2022010442A MX 2022010442 A MX2022010442 A MX 2022010442A MX 2022010442 A MX2022010442 A MX 2022010442A
Authority
MX
Mexico
Prior art keywords
methoxyphenyl
trifluoromethyl
fluoro
phenyl
acetic acid
Prior art date
Application number
MX2022010442A
Other languages
English (en)
Inventor
Helmut Buschmann
Thomas Goldner
Bertran Jordi Carles Ceron
Original Assignee
Aic246 Ag & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aic246 Ag & Co Kg filed Critical Aic246 Ag & Co Kg
Publication of MX2022010442A publication Critical patent/MX2022010442A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a la sal de potasio del ácido 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi- 5-(trifluorometil)fenil]-4H-quinazolin-4-il] acético y solvatos de la misma. La invención se refiere además a métodos de preparación de dicha sal de potasio del ácido 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi- 5-(trifluorometil)fenil]-4H-quinazolin-4-il] acético o solvatos de la misma, así como composiciones farmacéuticas que comprenden dicha sal.
MX2022010442A 2020-02-27 2021-03-01 Sal de potasio del acido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)pipe razin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4- il]acetico. MX2022010442A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20159742 2020-02-27
PCT/EP2021/055078 WO2021170882A1 (en) 2020-02-27 2021-03-01 Potassium salt of 2-[(4s)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4h-quinazolin-4-yl]acetic acid

Publications (1)

Publication Number Publication Date
MX2022010442A true MX2022010442A (es) 2022-10-18

Family

ID=69742731

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010442A MX2022010442A (es) 2020-02-27 2021-03-01 Sal de potasio del acido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)pipe razin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4- il]acetico.

Country Status (19)

Country Link
US (1) US20230150950A1 (es)
EP (1) EP4110471A1 (es)
JP (1) JP2023524349A (es)
KR (1) KR20220148860A (es)
CN (1) CN115427112A (es)
AR (1) AR121437A1 (es)
AU (1) AU2021227281A1 (es)
BR (1) BR112022016890A2 (es)
CA (1) CA3169075A1 (es)
CL (1) CL2022002294A1 (es)
CO (1) CO2022012006A2 (es)
CU (1) CU20220046A7 (es)
EC (1) ECSP22066666A (es)
IL (1) IL295644A (es)
MX (1) MX2022010442A (es)
PE (1) PE20230512A1 (es)
TW (1) TWI819279B (es)
UY (1) UY39097A (es)
WO (1) WO2021170882A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
DE102005027517A1 (de) 2005-06-15 2006-12-21 Bayer Healthcare Ag Verfahren zur Herstellung von Dihydrochinazolinen
DE102012101659A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Salze eines Dihydrochinazolinderivats

Also Published As

Publication number Publication date
BR112022016890A2 (pt) 2022-12-06
CO2022012006A2 (es) 2022-11-18
CA3169075A1 (en) 2021-09-02
US20230150950A1 (en) 2023-05-18
KR20220148860A (ko) 2022-11-07
CL2022002294A1 (es) 2023-02-03
IL295644A (en) 2022-10-01
JP2023524349A (ja) 2023-06-12
UY39097A (es) 2021-09-30
PE20230512A1 (es) 2023-03-24
ECSP22066666A (es) 2022-12-30
WO2021170882A1 (en) 2021-09-02
TW202140455A (zh) 2021-11-01
TWI819279B (zh) 2023-10-21
CN115427112A (zh) 2022-12-02
AU2021227281A1 (en) 2022-10-13
CU20220046A7 (es) 2023-04-10
EP4110471A1 (en) 2023-01-04
AR121437A1 (es) 2022-06-08

Similar Documents

Publication Publication Date Title
RU2412935C2 (ru) Феноксиуксусные кислоты в качестве активаторов дельта рецепторов ppar
NZ592801A (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
CY1117796T1 (el) Μετα νατριου και ασβεστιου αλατα παραγωγου διυδροκινζολινης και η χρηση αυτων ως αντι-ιικα μεσα
EA202091893A1 (ru) Новые кристаллические формы
CN1777577A (zh) 抗菌剂
NZ604035A (en) Glycine transporter-1 inhibitors, methods of making them, and uses thereof
EA200901514A1 (ru) Новая сольватная и кристаллическая форма производных карбамоилциклогексана
MX2010009401A (es) Forma cristalina de derivado de fenilamino pirimidina.
NZ589504A (en) Substituted carbinol compound having cyclic linker
EA200700648A1 (ru) 4-((феноксиалкил)тио)феноксиуксусные кислоты и аналоги
MX2022010442A (es) Sal de potasio del acido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)pipe razin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4- il]acetico.
MX2022000955A (es) Derivados de n-(6-metoxi)pirizadin-3-il) amina, n-metilo como moduladores de autotaxina (atx) para el tratamiento de enfermedades inflamatorias de las vias respiratorias o fibroticas.
CA2521258A1 (en) 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
EA200700647A1 (ru) 4-((феноксиалкил)тио)феноксиуксусные кислоты и аналоги
EA200600878A1 (ru) Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar )
EA202191620A1 (ru) Твердые формы, содержащие (s)-4-(4-(4-(((2-(2,6-диоксопиперидин-3-ил)-1-оксоизоиндолин-4-ил)окси)метил)бензил)пиперазин-1-ил)-3-фторбензонитрил и его соли, и содержащие их композиции и способы их применения
DE602006020624D1 (de) Verfahren zur herstellung eines pharmazeutischen zwischenprodukts
CL2022002290A1 (es) Acetato de sodio monohidrato, su preparación y uso
MX2013006419A (es) Compuestos carboxamida y su uso como inhibidores de calpaina v.
PH12020551121A1 (en) Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide
EA202192167A1 (ru) Форма соединения, обладающая повышенной биодоступностью, и ее составы
MX2021003282A (es) Métodos para producir compuestos de pirazol.
EA202191904A1 (ru) Фармацевтические композиции, содержащие (s)-4-(4-(4-(((2-(2,6-диоксопиперидин-3-ил)-1-оксоизоиндолин-4-ил)окси)метил)бензил)пиперазин-1-ил)-3-фторбензонитрил и способы их применения
MX2021008768A (es) Metodo para la produccion de acido 4-ciano benzoico o sus sales.
EP3854783A4 (en) NEW SALT OF ACID 4 - (\ {(4S) -1- (4-CARBAMIMIDOYLBENZOYL) -4- [4- (METHYLSULFONYL) PIPERAZIN-1-YL] -L-PROLYL \} AMINO) BENZOIC AND NEW FORM CRYSTALLINE DUDIT SALT